CP2 Small Organic Molecules from Natural Sources: The End of an Era?
DOI:
https://doi.org/10.3407/6pdrpq94Keywords:
Natural Products, Drug Discovery, Therapeutic InnovationAbstract
The multinational pharmaceutical industry (Big Pharma) has transitioned towards the development of macromolecules through heterologous production platforms, aiming to protect substantial financial investments associated with developing new therapies.
References
[1] ACHARYA, A., et al. (2024). How to Nurture Natural Products to Create New Therapeutics: Strategic Innovations and Molecule-to-Medicinal Insights into Therapeutic Advancements. Drug Discovery Today 29(12). [DOI]
[2] ZONA RUBIO, D. C., et al. (2025). Innovations in Snake Venom-Derived Therapeutics: A Systematic Review of Global Patents and Their Pharmacological Applications. Toxins 17(3). [DOI]
[3] ARORA, P., et al. (2025). Innovative Approaches in Acetylcholinesterase Inhibition: A Pathway to Effective Alzheimer’s Disease Treatment. Molecular Diversity 10.1007/s11030-025-11170-1. [DOI]
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Guillermo León Montoya Peláez
This work is licensed under a Creative Commons Attribution 4.0 International License.
License Terms
The Creative Commons Attribution License (CC BY 4.0) allows users to copy, distribute and transmit an article and adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity.
How to Cite
